EMEA-001988-PIP01-16-M01

Key facts

Invented name
GHRYVELIN (previously Macimorelin Aeterna Zentaris)
Active substance
Macimorelin
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0076/2020
PIP number
EMEA-001988-PIP01-16-M01
Pharmaceutical form(s)
Granules for oral solution
Condition(s) / indication(s)
Diagnosis of growth hormone deficiency
Route(s) of administration
Oral use
Contact for public enquiries
Aeterna Zentaris GmbH

E-mail: macrilen@aezsinc.com
Tel.: +49 69426023472

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating
Average
1 rating